Published ahead of print on July 7, 2005, doi:10.1164/rccm.200412-1647OC
Am. J. Respir. Crit. Care Med., Volume 172, Number 8, October 2005, 962-971
A more recent version of this article appeared on October 15, 2005
Submitted on December 8, 2004
Accepted on July 3, 2005
IK-B Kinase-2 Inhibitor Blocks Inflammation in Human Airway Smooth Muscle and a rat Model of Asthma
Mark A Birrell1, Elizabeth Hardaker1, Sissie Wong1, Kerryn McCluskie1, Matthew Catley1, Jorge De Alba1, Robert Newton1, Saleem Haj-Yahia2, K. Tao Pun3, Clarissa J Watts3, Robert J Shaw3, Tony J Savage3, and Maria G Belvisi1*
1 Department of Respiratory Pharmacology, Imperial College, Faculty of Medicine, National Heart and Lung Institute, London, United Kingdom,
2 Royal Brompton and Harefield Hospital, London, United Kingdom,
3 Department of Asthma Biology and Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline PLC, Stevenage, United Kingdom
* To whom correspondence should be addressed. E-mail: m.belvisi{at}imperial.ac.uk.
Rationale: NF- B is a transcription factor known to regulate the expression of many inflammatory genes including cytokines, chemokines and adhesion molecules. NF-B is held inactive in the cytoplasm, bound to I-B. The removal of I-B, via the actions of I-B kinase-2, allows NF-B to enter the nucleus.
Objectives: To determine the impact of inhibiting I-B kinase-2 on in vitro and in vivo models of airway inflammation.
Methods: The effect of inhibiting I-B kinase-2 was assessed in stimulated, cultured, primary human airway smooth muscle cells and an antigen-driven rat model of lung
inflammation.
Measurements: The release of cytokines from cultured cells and inflammatory cytokine expression and cellular burden in the lung were determined.
Main results: Two structurally distinct molecules and dominant negative technology, demonstrated that inhibition of I-B kinase-2 activity completely blocked cytokine release from cultured cells. Whereas, the two glucocorticoid comparators had limited impact on G-CSF, IL-8 and eotaxin release. Additionally, in an in vivo antigen driven model of airway inflammation the I-B kinase-2 inhibitor blocked NF-B nuclear translocation, which was associated with a reduction in inflammatory cytokine gene and protein expression, airway eosinophilia and late asthmatic reaction, similar in magnitude to that obtained with budesonide.
Conclusion: this study demonstrates that inhibiting I-B kinase-2 results in a general reduction of the inflammatory response in vitro and in vivo. Compounds of this class could have therapeutic utility in the treatment of asthma and may, in certain respects, possess a beneficial efficacy profile compared to that of a steroid.
Key words: Lung, asthma, rodent, NF-KB inhibitor
This article has been cited by other articles:
|
|
|
|
 
C. D. Sommers, J. M. Thompson, J. A. Guzova, S. L. Bonar, R. K. Rader, S. Mathialagan, N. Venkatraman, V. W. Holway, L. E. Kahn, G. Hu, et al.
Novel Tight-Binding Inhibitory Factor-{kappa}B Kinase (IKK-2) Inhibitors Demonstrate Target-Specific Anti-Inflammatory Activities in Cellular Assays and following Oral and Local Delivery in an in Vivo Model of Airway Inflammation
J. Pharmacol. Exp. Ther.,
August 1, 2009;
330(2):
377 - 388.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Kang, B. S. Kim, T. G. Uhm, S.-H. Lee, G. R. Lee, C.-S. Park, and I. Y. Chung
{gamma}-Secretase Inhibitor Reduces Allergic Pulmonary Inflammation by Modulating Th1 and Th2 Responses
Am. J. Respir. Crit. Care Med.,
May 15, 2009;
179(10):
875 - 882.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Bao, S. Guan, C. Cheng, S. Wu, S. H. Wong, D. M. Kemeny, B. P. Leung, and W. S. F. Wong
A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-{kappa}B Pathway
Am. J. Respir. Crit. Care Med.,
April 15, 2009;
179(8):
657 - 665.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Kondo, K. Fukuda, T. Adachi, and T. Nishida
Inhibition by a Selective I{kappa}B Kinase-2 Inhibitor of Interleukin-1-Induced Collagen Degradation by Corneal Fibroblasts in Three-Dimensional Culture
Invest. Ophthalmol. Vis. Sci.,
November 1, 2008;
49(11):
4850 - 4857.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Birrell, J. De Alba, M. C. Catley, E. Hardaker, S. Wong, M. Collins, D. L. Clarke, S. N. Farrow, T. M. Willson, J. L. Collins, et al.
Liver X Receptor Agonists Increase Airway Reactivity in a Model of Asthma via Increasing Airway Smooth Muscle Growth
J. Immunol.,
September 15, 2008;
181(6):
4265 - 4271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Zuyderduyn, M. B. Sukkar, A. Fust, S. Dhaliwal, and J. K. Burgess
Treating asthma means treating airway smooth muscle cells
Eur. Respir. J.,
August 1, 2008;
32(2):
265 - 274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Catley, M. A. Birrell, E. L. Hardaker, J. de Alba, S. Farrow, S. Haj-Yahia, and M. G. Belvisi
Estrogen Receptor {beta}: Expression Profile and Possible Anti-Inflammatory Role in Disease
J. Pharmacol. Exp. Ther.,
July 1, 2008;
326(1):
83 - 88.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Birrell, M. C. Catley, E. Hardaker, S. Wong, T. M. Willson, K. McCluskie, T. Leonard, S. N. Farrow, J. L. Collins, S. Haj-Yahia, et al.
Novel Role for the Liver X Nuclear Receptor in the Suppression of Lung Inflammatory Responses
J. Biol. Chem.,
November 2, 2007;
282(44):
31882 - 31890.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Tudhope, M. C. Catley, P. S. Fenwick, R. E. K. Russell, W. L. Rumsey, R. Newton, P. J. Barnes, and L. E. Donnelly
The Role of I{kappa}B Kinase 2, but Not Activation of NF-{kappa}B, in the Release of CXCR3 Ligands from IFN-{gamma}-Stimulated Human Bronchial Epithelial Cells
J. Immunol.,
November 1, 2007;
179(9):
6237 - 6245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Bao, S. Lim, W. Liao, Y. Lin, C. Thiemermann, B. P. Leung, and W. S. F. Wong
Glycogen Synthase Kinase-3beta Inhibition Attenuates Asthma in Mice
Am. J. Respir. Crit. Care Med.,
September 1, 2007;
176(5):
431 - 438.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang, M. Adner, and L.-O. Cardell
IL-1beta-Induced Transcriptional Up-Regulation of Bradykinin B1 and B2 Receptors in Murine Airways
Am. J. Respir. Cell Mol. Biol.,
June 1, 2007;
36(6):
697 - 705.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Newton, N. S. Holden, M. C. Catley, W. Oyelusi, R. Leigh, D. Proud, and P. J. Barnes
Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule I{kappa}B Kinase Inhibitors
J. Pharmacol. Exp. Ther.,
May 1, 2007;
321(2):
734 - 742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Keslacy, O. Tliba, H. Baidouri, and Y. Amrani
Inhibition of Tumor Necrosis Factor-{alpha}-Inducible Inflammatory Genes by Interferon-{gamma} Is Associated with Altered Nuclear Factor-{kappa}B Transactivation and Enhanced Histone Deacetylase Activity
Mol. Pharmacol.,
February 1, 2007;
71(2):
609 - 618.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Birrell, K. McCluskie, E. Hardaker, R. Knowles, and M. G. Belvisi
Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model
Eur. Respir. J.,
December 1, 2006;
28(6):
1236 - 1244.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Issa, S. Xie, K.-Y. Lee, R. D. Stanbridge, P. Bhavsar, M. B. Sukkar, and K. F. Chung
GRO-{alpha} regulation in airway smooth muscle by IL-1beta and TNF-{alpha}: role of NF-{kappa}B and MAP kinases
Am J Physiol Lung Cell Mol Physiol,
July 1, 2006;
291(1):
L66 - L74.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Birrell, S. Wong, E. L. Hardaker, M. C. Catley, K. McCluskie, M. Collins, S. Haj-Yahia, and M. G. Belvisi
I{kappa}B Kinase-2-Independent and -Dependent Inflammation in Airway Disease Models: Relevance of IKK-2 Inhibition to the Clinic
Mol. Pharmacol.,
June 1, 2006;
69(6):
1791 - 1800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med.,
April 1, 2006;
173(7):
698 - 706.
[Full Text]
[PDF]
|
|
|
Copyright © 2005 American Thoracic Society
|
|
|
